Compare GRANULES INDIA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs CONCORD DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA CONCORD DRUGS GRANULES INDIA/
CONCORD DRUGS
 
P/E (TTM) x 16.6 7.1 232.8% View Chart
P/BV x 3.7 1.1 329.7% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 GRANULES INDIA   CONCORD DRUGS
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
CONCORD DRUGS
Mar-21
GRANULES INDIA/
CONCORD DRUGS
5-Yr Chart
Click to enlarge
High Rs43833 1,317.3%   
Low Rs13813 1,091.3%   
Sales per share (Unadj.) Rs130.758.8 222.5%  
Earnings per share (Unadj.) Rs22.23.8 590.8%  
Cash flow per share (Unadj.) Rs28.35.3 532.3%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs86.830.6 283.6%  
Shares outstanding (eoy) m247.678.74 2,833.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.20.4 563.9%   
Avg P/E ratio x13.06.1 212.3%  
P/CF ratio (eoy) x10.24.3 235.7%  
Price / Book Value ratio x3.30.7 442.4%  
Dividend payout %6.80-   
Avg Mkt Cap Rs m71,337201 35,549.2%   
No. of employees `000NANA-   
Total wages/salary Rs m3,24335 9,356.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m32,375514 6,304.0%  
Other income Rs m2691 28,296.8%   
Total revenues Rs m32,644515 6,344.6%   
Gross profit Rs m8,55270 12,247.3%  
Depreciation Rs m1,51514 11,096.2%   
Interest Rs m26314 1,851.0%   
Profit before tax Rs m7,04443 16,411.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,54910 15,337.1%   
Profit after tax Rs m5,49533 16,741.6%  
Gross profit margin %26.413.6 194.3%  
Effective tax rate %22.023.5 93.4%   
Net profit margin %17.06.4 265.6%  
BALANCE SHEET DATA
Current assets Rs m19,970360 5,545.5%   
Current liabilities Rs m11,731162 7,225.3%   
Net working cap to sales %25.438.5 66.1%  
Current ratio x1.72.2 76.8%  
Inventory Days Days160 5,621.9%  
Debtors Days Days8631,473 58.6%  
Net fixed assets Rs m17,157139 12,367.9%   
Share capital Rs m24887 283.3%   
"Free" reserves Rs m21,262180 11,797.3%   
Net worth Rs m21,510268 8,036.3%   
Long term debt Rs m3,4116 56,574.3%   
Total assets Rs m37,127499 7,442.8%  
Interest coverage x27.84.0 691.1%   
Debt to equity ratio x0.20 704.0%  
Sales to assets ratio x0.91.0 84.7%   
Return on assets %15.59.4 164.5%  
Return on equity %25.512.3 208.3%  
Return on capital %29.320.9 140.5%  
Exports to sales %81.90-   
Imports to sales %26.80-   
Exports (fob) Rs m26,528NA-   
Imports (cif) Rs m8,691NA-   
Fx inflow Rs m26,5280-   
Fx outflow Rs m8,6910-   
Net fx Rs m17,8370-   
CASH FLOW
From Operations Rs m4,32516 26,762.3%  
From Investments Rs m-2,771-37 7,559.6%  
From Financial Activity Rs m-2,99321 -14,431.7%  
Net Cashflow Rs m-1,4410 -626,491.3%  

Share Holding

Indian Promoters % 41.6 49.0 85.0%  
Foreign collaborators % 0.4 0.0 -  
Indian inst/Mut Fund % 25.7 0.0 -  
FIIs % 21.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 51.0 113.8%  
Shareholders   216,385 3,071 7,046.1%  
Pledged promoter(s) holding % 7.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


Jan 21, 2022 (Close)

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA - CIAN HEALTHCARE COMPARISON

COMPARE GRANULES INDIA WITH

MARKET STATS